Bortezomib for refractory acute antibody-mediated rejection in kidney transplant recipients: A single-centre case series-Reference-Cited by-同舟云学术

Bortezomib for refractory acute antibody-mediated rejection in kidney transplant recipients: A single-centre case series

Published:2016-07-19 Issue:8 Volume:21 Page:700-704
ISSN:1320-5358
Container-title:Nephrology
language:en
Short-container-title:Nephrology

Author:

De Sousa-Amorim Erika¹,Revuelta Ignacio¹²,Diekmann Fritz¹²,Cofan Frederic¹,Lozano Miquel³,Cid Joan³,Palou Eduard⁴,Sole Manel⁵,Campistol Josep María¹²,Oppenheimer Federic¹²

Affiliation:

1. Nephrology; Hospital Clinic Barcelona; Barcelona Spain

2. Laboratori Experimental de Nefrologia i Trasplantament (LENIT); CRB CELLEX

3. Hemotherapy and Hemostasis; Hospital Clinic Barcelona; Barcelona Spain

4. Immunology; Hospital Clinic Barcelona; Barcelona Spain

5. Histopathology; Hospital Clinic Barcelona; Barcelona Spain

Publisher

Wiley

Subject

Nephrology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/nep.12659/fullpdf

Reference25 articles.

1. Determinants of poor graft outcome in patients with antibody-mediated acute rejection;Lefaucheur;Am. J. Transplant.,2007

2. The effect of desensitization protocols on human splenic B-cell populations in vivo;Ramos;Am. J. Transplant.,2007

3. Proteasome inhibition for antibody-mediated allograft rejection;Sadaka;Semin. Hematol.,2012

4. Proteasome inhibitor-based therapy for antibody-mediated rejection;Walsh;Kidney Int.,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Difficulties In Qualifying for Kidney Transplantation In a Highly Immunized Patient With Urinary Tract Defects;Transplantation Proceedings;2022-05

2. Emerging New Approaches in Desensitization: Targeted Therapies for HLA Sensitization;Frontiers in Immunology;2021-06-11

3. Incidence, risk factors, and long‐term outcomes associated with antibody‐mediated rejection — The long‐term Deterioration of Kidney Allograft Function (DeKAF) prospective cohort study;Clinical Transplantation;2021-05-18

4. Incidence, risk factors, treatment, and consequences of antibody‐mediated kidney transplant rejection: A systematic review;Clinical Transplantation;2021-05-05

5. Rejection Challenges: Diagnosis and Management;Challenges in Pediatric Kidney Transplantation;2021